Mammography reading is faced with an increasing volume of data from multiple sources, staff shortages, and more intricate reading due to the rise of tomosynthesis in screening programs. Radiologists are challenged with an increased workload and are often under pressure to produce results faster. As the digital transformation of healthcare continues, advanced, multimodal visualization solutions for breast health are needed to transform clinical operations.
MAMMOVISTA B.smart: Full spectrum. Exceptional performance.
MAMMOVISTA B.smart covers the full spectrum of multimodal diagnostics from mammography to MRI and ultrasound. An agile, vendor-neutral solution, it delivers exceptional performance for radiologists faced with more time-consuming tomosynthesis reading. Fully integrated next-gen AI support2 as well as side-by-side analysis of the related MR data is available in one view.
Real-time multimodality analytics allows for immediate comparison of all available patient data with specific MRI layouts and comprehensive functionalities in one view.1
Características y Beneficios
Designed for speed
Operational performance and reading speed have the potential to increase significantly with up to 75%3 faster image loading, while next-gen AI2 helps increase diagnostic accuracy by 10%4. The full spectrum of multimodality data and MRI analytics is available for real-time diagnostics and immediate comparisons.
Delightful to use
Intuitiveness and ease of use are essential success criteria for any domain-specific software interface used for intricate clinical or therapeutic decision making. MAMMOVISTA B.smart features a game-changing new interface based on the SHUI5 design framework that is absolutely delightful to use. Multiple workflows for screening or diagnostics and seamless double-blind reading8 management ease your daily routine.
Connected for real outcomes
Clear clinical values stem from optimizing the management of growing workloads: Combining faster reading performance with AI-powered tools2, MAMMOVISTA B.smart improves your economic performance with up to 15% optimized TCO costs3 and a 63%6 reduction in workload.
Best Fit: MAMMOMAT Revelation and MAMMOVISTA B.smart
- Experience the highest depth resolution7 with the unique 50° wide-angle tomosynthesis of MAMMOMAT Revelation combined with MAMMOVISTA B.smart and fast tomo reading
- Stay on top of clinical developments with integrated TiCEM8 and Insight BD8, a universal multimodality approach for comprehensive breast care reading
- Deliver instant risk stratification with Insight BD’s8 ideally-adapted layouts and Multiple ReportFlows
”Artificial intelligence could mean that one of the two radiologists reading the patient’s breast images could take on other tasks in future since the second evaluation can be done automatically.”
"It's like having an additional colleague at the press of a button."
Watch our latest expert talks
Increasing diagnostic accuracy with next-gen AI
Dr. Hamm is a radiology specialist at the Radiologische Gemeinschaftspraxis in Chemnitz, a mammography screening center for the district of Central Saxony. In the video, he talks about the challenges in breast screening and possible future improvements in screening and diagnostics with the support of artificial intelligence. Additionally, he presents the results of his recently conducted study that shows the potential of Artificial Intelligence to reduce the recall rate and consensus meeting workload in breast cancer screening with digital mammography.
Artificial Intelligence in Mammography: Leveling the Playing Field for Global Disparities
In her keynote talk Prof. Dr. Rachel Brem (George Washington University, Washington, USA) reviews the impact of Artificial intelligence (AI) in cancer detection and compares AI to radiologist interpretation with 2D and 3D mammograms. (Clinical Focus Talks, Nov. 2021)
AI in Breast Screening and Diagnostics – the Evidence and Clinical Implementation
Prof. Dr. Nico Karssemeijer (ScreenPoint Medical, Nijmegen/The Netherlands) and Henny Rijken (ScreenPoint Medical, Nijmegen/The Netherlands) talk about Artificial Intelligence (AI) in breast screening and diagnostics and give an overview of evidence and clinical implementation. (July 2020)
See how MAMMOVISTA B.smart works
Advanced solutions to increase accuracy
Superior image quality and high-speed tomo reading with full-spectrum multimodal diagnostics can improve patient care and data management in a holistic and personalized approach.
Discover a new world of reading routine with our full-spectrum diagnostics solution with Syngo Carbon in one view. Next-Gen AI-powered solutions2 can increase accuracy, reduce workloads and optimize reading strategies.
¿Fue útil esta información?
This feature is an option and available with MAMMOVISTA B.smart VB70
This feature is an option and available with MAMMOVISTA B.smart. Transpara® Powered by FusionAI, ScreenPoint Medical.
Data on file.
van Winkel SL, Rodríguez-Ruiz A, Appelman L, Gubern-Mérida A, Karssemeijer N, Teuwen J, Wanders AJT, Sechopoulos I, Mann RM. Impact of artificial intelligence support on accuracy and reading time in breast tomosynthesis image interpretation: a multi-reader multi-case study. Eur Radiol. 2021;31:8682-8691.
SHUI stands for Siemens Healthineers User Interface.
Lauritzen AD, Rodríguez-Ruiz A, von Euler-Chelpin MC, Lynge E, Vejborg I, Nielsen M, Karssemeijer N, Lillholm M.
An Artificial Intelligence-based Mammography Screening Protocol for Breast Cancer: Outcome and Radiologist Workload. Radiology. 2022 Apr 19:210948
Maldera et al. (2016): Digital breast tomosynthesis: Dose and image quality assessment. Physica Medica, pp. 1-12.; Marshall N.W. and Bosmans H. (2012): Measurements of system sharpness for two digital breast tomosynthesis systems. Phys. Med. Biol. 57, pp. 7629-7650.; Rodríguez-Ruiz A. et al. (2016): Evaluation of the technical performance of three different commercial digital breast tomosynthesis systems in the clinical environment. Physica Medica 32, pp. 767-777.
MAMMOVISTA B.smart is not commercially available in all countries. Due to regulatory reasons its future availability cannot be guaranteed. Please contact your local Siemens Healthineers organization for further details.
Syngo Carbon is not commercially available in all countries. Due to regulatory reasons its future availability cannot be guaranteed. Please contact your local Siemens Healthineers organization for further details.
The statements by Siemens Healthineers' customer described herein are based on results that were achieved in the customer's unique setting. Since there is no "typical" hospital and many variables exist (e.g. hospital size, case mix, level of IT adoption) there can be no guarantee that other customers will achieve the same results.